IE42793L - Treatment of colitis - Google Patents

Treatment of colitis

Info

Publication number: IE42793L
Authority: IE; Ireland
Prior art keywords: colitis; treatment
Prior art date: 1975-04-09

Application number

IE760749A

Other versions

IE42793B1 (en

Original Assignee

Haessle Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1975-04-09

Filing date

1976-04-09

Publication date

1976-10-09

1976-04-09 Application filed by Haessle Ab filed Critical Haessle Ab

1976-10-09 Publication of IE42793L publication Critical patent/IE42793L/en

1980-10-22 Publication of IE42793B1 publication Critical patent/IE42793B1/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Plant Substances (AREA)

IE749/76A 1975-04-09 1976-04-09 Preparation for treatment of colitis IE42793B1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE7504049A SE7504049L (en)	1975-04-09	1975-04-09	COLON PREPARATION

Publications (2)

Publication Number	Publication Date
IE42793L true IE42793L (en)	1976-10-09
IE42793B1 IE42793B1 (en)	1980-10-22

Family

ID=20324216

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IE749/76A IE42793B1 (en)	1975-04-09	1976-04-09	Preparation for treatment of colitis

Country Status (12)

Country	Link
BE (1)	BE840552A (en)
DE (1)	DE2614296A1 (en)
DK (1)	DK153376A (en)
FI (1)	FI56772C (en)
FR (1)	FR2306710A1 (en)
GB (1)	GB1538123A (en)
IE (1)	IE42793B1 (en)
LU (1)	LU74732A1 (en)
NL (1)	NL7603600A (en)
NO (1)	NO761101L (en)
NZ (1)	NZ180552A (en)
SE (1)	SE7504049L (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS52139715A (en) *	1976-05-14	1977-11-21	Nippon Kayaku Co Ltd	Coated granules of alkali polyacrylate
FR2471186A1 (en) *	1979-12-10	1981-06-19	Roussel Uclaf	NEW COLIC DELITESCENCE TABLETS AND THEIR PREPARATION PROCESS
US4444761A (en) *	1981-05-04	1984-04-24	Syntex (U.S.A.) Inc.	Cellulose/carboxymethyl cellulose mixtures useful for controlling fecal output, and methods employing them
US4521401A (en) *	1983-01-03	1985-06-04	Verex Laboratories, Inc.	Constant release rate solid oral dosage formulations of quinidine
US4461759A (en) *	1983-01-03	1984-07-24	Verex Laboratories, Inc.	Constant release rate solid oral dosage formulations of veropamil
US4522804A (en) *	1983-01-03	1985-06-11	Verex Laboratories, Inc.	Constant release rate solid oral dosage formulations of propranolol
DE3776116D1 (en) *	1986-12-30	1992-02-27	American Cyanamid Co	COMPOSITION CONTAINING A POLYCARBOPHIL.
GB8817015D0 (en) *	1988-07-16	1988-08-17	Reckitt & Colmann Prod Ltd	Method of treatment
CA1327748C (en) *	1988-09-20	1994-03-15	Christopher William Quirk	Pharmaceutical composition containing ranitidine and alginic acid
IL98087A (en) *	1990-05-04	1996-11-14	Perio Prod Ltd	Colonic drug delivery system
JPH05508631A (en) *	1990-05-04	1993-12-02	イッサム・リサーチ・デベロップメント・カンパニー・オブ・ザ・ヒーブリュー・ユニバーシティー・オブ・エルサレム	Colonic drug delivery system
DE9212938U1 (en) *	1992-09-25	1992-11-26	Boehringer Ingelheim Gmbh, 6507 Ingelheim	Calcium polycarbophil preparation for taking high doses of active ingredients
US5840332A (en) *	1996-01-18	1998-11-24	Perio Products Ltd.	Gastrointestinal drug delivery system
JP2020516629A (en)	2017-04-14	2020-06-11	ジェレシス，エルエルシー	Compositions and methods for treating or preventing intestinal permeability-related disorders

1975
- 1975-04-09 SE SE7504049A patent/SE7504049L/en unknown
1976
- 1976-03-30 NO NO761101A patent/NO761101L/no unknown
- 1976-03-31 DK DK153376A patent/DK153376A/en not_active IP Right Cessation
- 1976-04-02 DE DE19762614296 patent/DE2614296A1/en not_active Withdrawn
- 1976-04-06 NL NL7603600A patent/NL7603600A/en not_active Application Discontinuation
- 1976-04-07 FI FI760948A patent/FI56772C/en not_active IP Right Cessation
- 1976-04-08 FR FR7610342A patent/FR2306710A1/en active Granted
- 1976-04-08 GB GB14390/76A patent/GB1538123A/en not_active Expired
- 1976-04-08 NZ NZ180552A patent/NZ180552A/en unknown
- 1976-04-09 LU LU74732A patent/LU74732A1/xx unknown
- 1976-04-09 BE BE165981A patent/BE840552A/en unknown
- 1976-04-09 IE IE749/76A patent/IE42793B1/en unknown

Also Published As

Publication number	Publication date
DK153376A (en)	1976-10-10
FR2306710B1 (en)	1979-07-13
FR2306710A1 (en)	1976-11-05
GB1538123A (en)	1979-01-10
DE2614296A1 (en)	1976-10-21
NL7603600A (en)	1976-10-12
FI56772B (en)	1979-12-31
FI760948A (en)	1976-10-10
BE840552A (en)	1976-10-11
IE42793B1 (en)	1980-10-22
NO761101L (en)	1976-10-12
SE7504049L (en)	1976-10-10
LU74732A1 (en)	1977-02-04
NZ180552A (en)	1978-07-28
FI56772C (en)	1980-04-10

Publication	Publication Date	Title
ZA765406B (en)	1977-10-26	Treatment of small articles
GB1550835A (en)	1979-08-22	Treatment of tobacco
AU2076476A (en)	1978-06-29	Aracterizat-ion of bodies
GB1543157A (en)	1979-03-28	Treatment of fibres
IL51153A0 (en)	1977-02-28	Treatment of waste
ZA764855B (en)	1977-07-27	Treatment of pigment
GB1540441A (en)	1979-02-14	Treatment of blood plasma
ZA764072B (en)	1977-06-29	Treatment of solid-liquid-gas mixtures
ZA764653B (en)	1977-08-31	Treatment of endotoxaemia
ZA763339B (en)	1977-05-25	Treatment of pigment
IE42793L (en)	1976-10-09	Treatment of colitis
GB1554283A (en)	1979-10-17	Treatment of glass
JPS5210834A (en)	1977-01-27	Surface treatment of metal
ZA762669B (en)	1977-04-27	Treatment of neoplasias
JPS5212976A (en)	1977-01-31	Treatment of unicellular preotein
ZA763340B (en)	1977-05-25	Treatment of pigment
JPS51139618A (en)	1976-12-02	Treatment of animal
ZA765733B (en)	1977-09-28	Treatment of effluent
JPS5218810A (en)	1977-02-12	Complex medical composition of estrogennprostaglangin
ZA762513B (en)	1977-04-27	Treatment of tire making components
JPS5242997A (en)	1977-04-04	Treatment of wool
GB1547293A (en)	1979-06-06	Treatment of materials with organo-halosilanes
PH12349A (en)	1979-01-29	Treatment of seedlings
ZA765293B (en)	1977-09-28	Treatment of electrodes
JPS51120940A (en)	1976-10-22	Surface treatment of metals